Nuria M. Vivas

936 total citations
26 papers, 816 citations indexed

About

Nuria M. Vivas is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Nuria M. Vivas has authored 26 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 13 papers in Pharmacology and 8 papers in Organic Chemistry. Recurrent topics in Nuria M. Vivas's work include Cholinesterase and Neurodegenerative Diseases (13 papers), Receptor Mechanisms and Signaling (12 papers) and Chemical synthesis and alkaloids (8 papers). Nuria M. Vivas is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (13 papers), Receptor Mechanisms and Signaling (12 papers) and Chemical synthesis and alkaloids (8 papers). Nuria M. Vivas collaborates with scholars based in Spain, United Kingdom and France. Nuria M. Vivas's co-authors include Albert Badı́a, Josep-Eladı́ Baños, Pelayo Camps, Diego Muñoz‐Torrero, Elisabet Vila, Jesús Giraldo, Modesto Orozco, F. Javier Luque, Xavier Barril and Rachid El Achab and has published in prestigious journals such as Brain Research, Journal of Medicinal Chemistry and British Journal of Pharmacology.

In The Last Decade

Nuria M. Vivas

26 papers receiving 782 citations

Peers

Nuria M. Vivas
Monika Głuch‐Lutwin Poland
Monika Marcinkowska Poland
Gunjan Saxena India
Gina M. Bores United States
Albert Badı́a Spain
Esther García‐Palomero Spain
Wayne W. Petko United States
Erez Podoly Israel
M. Victòria Clos Spain
Santosh Kumar Prajapati India
Monika Głuch‐Lutwin Poland
Nuria M. Vivas
Citations per year, relative to Nuria M. Vivas Nuria M. Vivas (= 1×) peers Monika Głuch‐Lutwin

Countries citing papers authored by Nuria M. Vivas

Since Specialization
Citations

This map shows the geographic impact of Nuria M. Vivas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nuria M. Vivas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nuria M. Vivas more than expected).

Fields of papers citing papers by Nuria M. Vivas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nuria M. Vivas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nuria M. Vivas. The network helps show where Nuria M. Vivas may publish in the future.

Co-authorship network of co-authors of Nuria M. Vivas

This figure shows the co-authorship network connecting the top 25 collaborators of Nuria M. Vivas. A scholar is included among the top collaborators of Nuria M. Vivas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nuria M. Vivas. Nuria M. Vivas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vivas, Nuria M., et al.. (2005). Effects of (±)-huprine Y and (±)-huprine Z, two new anticholinesterasic drugs, on muscarinic receptors. Neuroscience Letters. 379(2). 106–109. 8 indexed citations
2.
Vivas, Nuria M., et al.. (2003). Characterisation of the anticholinesterase activity of two new tacrine–huperzine A hybrids. Neuropharmacology. 44(6). 749–755. 31 indexed citations
3.
Giraldo, Jesús, Nuria M. Vivas, Elisabet Vila, & Albert Badı́a. (2002). Assessing the (a)symmetry of concentration-effect curves. Pharmacology & Therapeutics. 95(1). 21–45. 111 indexed citations
4.
Roman, Shilina, Nuria M. Vivas, A. Badía, & M. Victòria Clos. (2002). Interaction of a new potent anticholinesterasic compound (±)huprine X with muscarinic receptors in rat brain. Neuroscience Letters. 325(2). 103–106. 20 indexed citations
5.
6.
Badı́a, Albert, et al.. (2001). Different α 1 -adrenoceptor-induced inositol phosphate formation in the two portions of rat vas deferens. Naunyn-Schmiedeberg s Archives of Pharmacology. 363(1). 11–15. 2 indexed citations
7.
Marco, José L., Cristóbal de los Rı́os, M. Carmo Carreiras, et al.. (2001). Synthesis and acetylcholinesterase/butyrylcholinesterase inhibition activity of new tacrine-like analogues. Bioorganic & Medicinal Chemistry. 9(3). 727–732. 60 indexed citations
8.
Camps, Pelayo, Rachid El Achab, Jordi Morral, et al.. (2000). New Tacrine−Huperzine A Hybrids (Huprines):  Highly Potent Tight-Binding Acetylcholinesterase Inhibitors of Interest for the Treatment of Alzheimer's Disease. Journal of Medicinal Chemistry. 43(24). 4657–4666. 170 indexed citations
9.
Camps, Pelayo, Rachid El Achab, Jordi Morral, et al.. (1999). Synthesis, in Vitro Pharmacology, and Molecular Modeling of Very Potent Tacrine−Huperzine A Hybrids as Acetylcholinesterase Inhibitors of Potential Interest for the Treatment of Alzheimer's Disease. Journal of Medicinal Chemistry. 42(17). 3227–3242. 86 indexed citations
10.
Baños, Josep-Eladı́, et al.. (1998). Synthesis and evaluation of tacrine–Huperzine a hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of alzheimer’s disease. Bioorganic & Medicinal Chemistry. 6(4). 427–440. 69 indexed citations
11.
Vila, Elisabet, et al.. (1997). α1‐Adrenoceptor vasoconstriction in the tail artery during ageing. British Journal of Pharmacology. 121(5). 1017–1023. 25 indexed citations
12.
Clos, M. Victòria, et al.. (1997). D2 dopamine receptors and modulation of spontaneous acetylcholine (ACh) release from rat striatal synaptosomes. British Journal of Pharmacology. 122(2). 286–290. 17 indexed citations
13.
Vivas, Nuria M., et al.. (1997). Use of the operational model of agonism and [3H]prazosin binding to assess altered responsiveness of α1-adrenoceptors in the vas deferens of spontaneously hypertensive rat. Naunyn-Schmiedeberg s Archives of Pharmacology. 356(3). 383–391. 15 indexed citations
14.
Vivas, Nuria M., et al.. (1996). Sources of calcium and α1‐adrenoceptor‐mediated contraction in rat tail artery. British Journal of Pharmacology. 118(8). 2067–2072. 4 indexed citations
15.
Giraldo, Jesús, et al.. (1996). Endothelial modulation of α1‐adrenoceptor contractile responses in the tail artery of spontaneously hypertensive rats. British Journal of Pharmacology. 119(4). 765–771. 16 indexed citations
16.
Vivas, Nuria M., et al.. (1995). Action on noradrenergic transmission of an anticholinesterase: 9-amino-1,2,3,4-tetrahydroacridine. Neuropharmacology. 34(4). 367–375. 3 indexed citations
17.
Escorihuela, Rosa M., Alberto Fernández‐Teruel, Adolf Tobeña, et al.. (1995). Early Environmental Stimulation Produces Long-Lasting Changes on β-Adrenoceptor Transduction System. Neurobiology of Learning and Memory. 64(1). 49–57. 55 indexed citations
18.
Orallo, Francisco, Marı́a Isabel Loza, Nuria M. Vivas, et al.. (1993). Study of the mechanism of the relaxant action of (+)‐glaucine in rat vas deferens. British Journal of Pharmacology. 110(3). 943–948. 10 indexed citations
19.
Vivas, Nuria M., et al.. (1993). Differential effects of physostigmine and 1,2,3,4-tetrahydro-9-aminoacridine on the ß-adrenoceptor transduction system. European Journal of Pharmacology Molecular Pharmacology. 245(1). 9–13. 4 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monika Głuch‐Lutwin Breakdown of academic impact, for papers by Monika Marcinkowska Breakdown of academic impact, for papers by Gunjan Saxena Breakdown of academic impact, for papers by Gina M. Bores Breakdown of academic impact, for papers by Albert Badı́a Breakdown of academic impact, for papers by Esther García‐Palomero Breakdown of academic impact, for papers by Wayne W. Petko Breakdown of academic impact, for papers by Erez Podoly Breakdown of academic impact, for papers by M. Victòria Clos Breakdown of academic impact, for papers by Santosh Kumar Prajapati
Rankless by CCL
2026